Profile data is unavailable for this security.
About the company
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
- Revenue in JPY (TTM)54.24bn
- Net income in JPY7.92bn
- Incorporated1981
- Employees1.22k
- LocationJapan Lifeline Co Ltd25F, NYK Tennoz Bldg.,2-2-20, Higashi-ShinagawaSHINAGAWA-KU 140-0002JapanJPN
- Phone+81 367115200
- Websitehttps://www.jll.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medikit Co Ltd | 22.29bn | 3.03bn | 52.03bn | 966.00 | 14.74 | 0.9651 | 11.76 | 2.33 | 197.42 | 197.42 | 1,453.36 | 3,015.35 | 0.4192 | 3.58 | 4.29 | 23,074,350.00 | 5.69 | 5.75 | 6.40 | 6.31 | 38.75 | 40.05 | 13.58 | 14.08 | 4.77 | 4,935.02 | 0.00 | 38.88 | 1.13 | 3.38 | 7.15 | 3.56 | -0.6005 | 12.20 |
| CI Medical Co Ltd | 47.75bn | 1.43bn | 52.50bn | 473.00 | 36.63 | 2.57 | 15.65 | 1.10 | 28.66 | 28.66 | 955.00 | 408.47 | 1.16 | 4.28 | 14.43 | 100,945,000.00 | 3.55 | 10.83 | 7.19 | 15.65 | 25.73 | 27.73 | 3.06 | 6.06 | 0.524 | 200.36 | 0.4835 | 12.83 | 6.38 | 12.07 | -17.41 | 9.38 | 77.24 | 13.65 |
| TAUNS Laboratories Inc | 18.43bn | 5.77bn | 58.00bn | 271.00 | 9.96 | 4.21 | 8.99 | 3.15 | 57.74 | 57.74 | 184.35 | 136.67 | -- | -- | -- | 68,025,330.00 | -- | -- | -- | -- | 67.80 | -- | 31.32 | -- | 1.16 | 341.33 | 0.4111 | -- | 17.62 | -- | 90.26 | -- | -- | -- |
| Japan Eyewear Holdings Co Ltd | 15.43bn | 3.01bn | 63.80bn | 542.00 | 21.33 | 4.36 | 13.92 | 4.14 | 124.12 | 124.12 | 637.46 | 607.45 | 0.4565 | 2.19 | 13.25 | 28,459,410.00 | 8.90 | -- | 10.18 | -- | 78.21 | -- | 19.50 | -- | 1.18 | 10.04 | 0.5285 | -- | 26.17 | -- | 659.25 | -- | -- | -- |
| Shofu Inc | 37.52bn | 4.46bn | 74.83bn | 1.37k | 16.71 | 1.79 | 18.29 | 1.99 | 125.14 | 125.14 | 1,052.79 | 1,168.62 | 0.7951 | 1.44 | 9.49 | 27,406,870.00 | 9.48 | 6.15 | 10.62 | 7.00 | 59.71 | 57.76 | 11.92 | 8.12 | 2.89 | -- | 0.0048 | 31.84 | 10.74 | 7.08 | 16.59 | 24.93 | 5.03 | 21.94 |
| Intermestic Inc | -100.00bn | -100.00bn | 77.63bn | 1.84k | -- | 7.28 | -- | -- | -- | -- | -- | 348.56 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.10 | -- | 0.494 | -- | 11.12 | -- | 102.26 | -- | -- | -- |
| Nagaileben Co., Ltd. | 16.41bn | 2.82bn | 79.48bn | 511.00 | 25.04 | 1.64 | 33.20 | 4.84 | 88.80 | 88.80 | 516.26 | 1,355.91 | 0.3488 | 1.48 | 3.29 | -- | 6.00 | 7.32 | 6.43 | 7.92 | 42.83 | 44.58 | 17.19 | 19.71 | 10.20 | -- | -- | 57.20 | -4.48 | -0.4484 | -12.53 | -3.91 | -6.53 | 0.00 |
| Eiken Chemical Co Ltd | 39.52bn | 2.33bn | 83.60bn | 757.00 | 33.51 | 1.62 | 25.63 | 2.12 | 64.72 | 64.72 | 1,103.44 | 1,339.12 | 0.6099 | 2.74 | 3.30 | 52,202,110.00 | 3.59 | 8.01 | 4.41 | 10.14 | 41.23 | 45.92 | 5.88 | 11.50 | 2.13 | -- | 0.0608 | 35.45 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
| Japan Lifeline Co., Ltd. | 54.24bn | 7.92bn | 97.65bn | 1.22k | 11.93 | 1.65 | 10.20 | 1.80 | 108.04 | 108.04 | 738.09 | 779.23 | 0.7759 | 1.41 | 4.07 | 44,602,800.00 | 11.33 | 8.63 | 14.02 | 10.88 | 60.32 | 57.28 | 14.60 | 12.28 | 1.62 | -- | 0.0885 | 48.80 | -0.7073 | 2.45 | 9.06 | -0.5446 | 5.40 | 7.69 |
| HOGY MEDICAL CO., LTD. | 29.29bn | 2.08bn | 102.09bn | 1.41k | 52.92 | 1.29 | 15.02 | 3.49 | 85.61 | 85.61 | 1,278.04 | 3,515.34 | 0.2912 | 1.99 | 2.33 | 20,801,850.00 | 2.06 | 4.24 | 2.27 | 4.67 | 32.53 | 39.76 | 7.09 | 11.58 | 3.80 | -- | 0.1621 | 45.68 | 0.3053 | 1.30 | -35.03 | -14.24 | 7.94 | 4.56 |
| Menicon Co Ltd | 118.64bn | 4.84bn | 128.77bn | 4.22k | 27.72 | 1.48 | 9.94 | 1.09 | 60.62 | 60.62 | 1,495.58 | 1,132.00 | 0.6615 | 2.85 | 8.68 | 28,106,370.00 | 2.70 | 4.53 | 3.36 | 5.67 | 53.41 | 52.97 | 4.08 | 5.72 | 1.28 | 109.35 | 0.4583 | 27.12 | 5.44 | 7.51 | -38.48 | 4.88 | 32.61 | 12.30 |
| PHC Holdings Corp | 360.94bn | -6.34bn | 132.03bn | 9.25k | -- | 1.03 | 5.88 | 0.3658 | -50.71 | -50.71 | 2,859.74 | 1,013.24 | 0.6587 | 3.48 | 5.67 | 39,042,080.00 | -1.17 | -0.0766 | -1.55 | -0.1164 | 45.47 | 47.71 | -1.78 | -0.1268 | 0.8238 | 0.7074 | 0.6779 | -- | -0.7109 | 13.66 | -300.16 | -- | 16.68 | -- |
Data as of Nov 15 2024. Currency figures normalised to Japan Lifeline Co Ltd's reporting currency: Japanese Yen JPY
17.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sompo Asset Management Co. Ltd.as of 15 Mar 2024 | 4.11m | 5.42% |
| The Vanguard Group, Inc.as of 02 Oct 2024 | 1.78m | 2.36% |
| Nomura Asset Management Co., Ltd.as of 03 Oct 2024 | 1.77m | 2.34% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 03 Oct 2024 | 993.40k | 1.31% |
| Nikko Asset Management Co., Ltd.as of 04 Oct 2024 | 920.20k | 1.22% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 920.10k | 1.22% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 877.90k | 1.16% |
| Daiwa Asset Management Co. Ltd.as of 30 Sep 2024 | 803.40k | 1.06% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 502.29k | 0.66% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 2024 | 352.40k | 0.47% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
